Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.52−0.14 (-8.16%)
Close on Nov 20, 2026Market cap $27.55MP/E –Yield –
Alterity Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2023 it was A$13.81M, up 7.5% from the year before. The highest annual figure on record is A$15.31M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | A$13.81M | +7.5% |
| FY2022 | Jun 30, 2022 | A$12.85M | -16.1% |
| FY2021 | Jun 30, 2021 | A$15.31M | +13.8% |
| FY2020 | Jun 30, 2020 | A$13.46M | +9.1% |
| FY2019 | Jun 30, 2019 | A$12.34M | – |
See a number that looks wrong?